Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J DeGraff

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
European Urology|December 1, 2009
Novel use of a combined artificial intelligence approach to identify patients with noninvasive urothelial cell carcinoma of the urinary bladder who are at greatest risk for progression to muscle-invasive disease: a step forwardDavid J DeGraff
Urologic Oncology|August 10, 2015
Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladderRosalyn M Adam, David J DeGraff
European Urology|January 4, 2011
Detection of tumor cells in the bone offers independent prognostic value in bladder cancer patients: the clinical and basic science perspectiveDavid J DeGraff, Peter E Clark
The Journal of Urology|May 16, 2012
Gender specific differences in bladder cancerDavid J DeGraff, Robert J Matusik
American Journal of Clinical and Experimental Urology|October 31, 2022
Characterization of laminin-332 gene expression in molecular subtypes of human bladder cancerVonn Walter, David J DeGraff, Hironobu Yamashita
The Prostate|December 18, 2009
The developmental expression profile of PAX2 in the murine prostateQian Chen, David J DeGraff, Robert A Sikes
Oncoscience|October 27, 2015
Tumorigenicity of RTK/RAS in urotheliumXue-Ru Wu, Cathy Mendelsohn, David J DeGraff
American Journal of Translational Research|December 4, 2009
Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesionsDavid J Degraff, Adam A Aguiar, Robert A Sikes
Molecular Endocrinology (Baltimore, Md.)|October 23, 2009
Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expressionQian Sun, Xiuping Yu, David J Degraff, et al.
American Journal of Clinical and Experimental Urology|September 25, 2018
Androgen represses opioid growth factor receptor (OGFR) in human prostate cancer LNCaP cells and OGFR expression in human prostate cancer tissueHironobu Yamashita, Lauren Shuman, Joshua I Warrick, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
European Urology|December 1, 2009
Novel use of a combined artificial intelligence approach to identify patients with noninvasive urothelial cell carcinoma of the urinary bladder who are at greatest risk for progression to muscle-invasive disease: a step forwardDavid J DeGraff
Urologic Oncology|August 10, 2015
Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladderRosalyn M Adam, David J DeGraff
European Urology|January 4, 2011
Detection of tumor cells in the bone offers independent prognostic value in bladder cancer patients: the clinical and basic science perspectiveDavid J DeGraff, Peter E Clark
The Journal of Urology|May 16, 2012
Gender specific differences in bladder cancerDavid J DeGraff, Robert J Matusik
American Journal of Clinical and Experimental Urology|October 31, 2022
Characterization of laminin-332 gene expression in molecular subtypes of human bladder cancerVonn Walter, David J DeGraff, Hironobu Yamashita
The Prostate|December 18, 2009
The developmental expression profile of PAX2 in the murine prostateQian Chen, David J DeGraff, Robert A Sikes
Oncoscience|October 27, 2015
Tumorigenicity of RTK/RAS in urotheliumXue-Ru Wu, Cathy Mendelsohn, David J DeGraff
American Journal of Translational Research|December 4, 2009
Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesionsDavid J Degraff, Adam A Aguiar, Robert A Sikes
Molecular Endocrinology (Baltimore, Md.)|October 23, 2009
Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expressionQian Sun, Xiuping Yu, David J Degraff, et al.
American Journal of Clinical and Experimental Urology|September 25, 2018
Androgen represses opioid growth factor receptor (OGFR) in human prostate cancer LNCaP cells and OGFR expression in human prostate cancer tissueHironobu Yamashita, Lauren Shuman, Joshua I Warrick, et al.
Pageof 7